PEARCE CATHERINE (Chief Operating Officer) exercised options at CINCOR PHARMA, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/19/2023ACC: 0001209191-23-004027
Officer· Chief Operating Officer
Since Jan 2022
-4K
Net shares
Net seller
$114.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
13.23K acquired · 17.23K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.23K
Price / share
—
Trade value
—
% of position
10.1%
1/11/2023
130.91K→144.15K
Common Stock
Direct
Shares
−4K
Price / share
$28.75
Trade value
$114.91K
% of position
2.8%
1/11/2023
144.15K→140.15K
Total
Net shares
+9.24K
Net value
-$114.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/11/2023 | M · Option Exercise | +13.23K | — | — | 10.1% | 130.91K | 144.15K |
| Common Stock Direct | 1/11/2023 | F · Tax Withholding | −4K | $28.75 | $114.91K | 2.8% | 144.15K | 140.15K |
| Total | +9.24K | -$114.91K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
13.23K shares
Shares
−13.23K
Strike price
Held after
13.24K
Exercisable
—
1/11/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock13.23K shares | 1/11/2023 | M · Option Exercise | −13.23K | — | 13.24K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.50K
Total
1.50K indirect1.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.50K | Indirect |
| Total | 1.50K | 1.50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported